Beijing Strong Biotechnologies (SZSE:300406) Other Net Income (Loss) : ¥-0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Beijing Strong Biotechnologies Other Net Income (Loss)?

Beijing Strong Biotechnologies's Other Net Income (Loss) for the three months ended in Mar. 2024 was ¥-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0 Mil.

Beijing Strong Biotechnologies's quarterly Other Net Income (Loss) increased from Sep. 2023 (¥-0 Mil) to Dec. 2023 (¥0 Mil) but then declined from Dec. 2023 (¥0 Mil) to Mar. 2024 (¥-0 Mil).

Beijing Strong Biotechnologies's annual Other Net Income (Loss) stayed the same from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥0 Mil) but then increased from Dec. 2022 (¥0 Mil) to Dec. 2023 (¥0 Mil).

Beijing Strong Biotechnologies Other Net Income (Loss) Historical Data

The historical data trend for Beijing Strong Biotechnologies's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Strong Biotechnologies Other Net Income (Loss) Chart

Beijing Strong Biotechnologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Beijing Strong Biotechnologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Beijing Strong Biotechnologies Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0 Mil.

Beijing Strong Biotechnologies Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Beijing Strong Biotechnologies's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Strong Biotechnologies (SZSE:300406) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Beijing Strong Biotechnologies Inc (SZSE:300406) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 15 Hua Yuan Dong Lu, 5th Floor, Kuang Yi Building, Haidian District, Beijing, CHN, 100191

Website

http://www.bsbe.com.cn

Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.

Executives

Shuang He	Executives
Luo Ai Ping	Director
	Directors, executives
Liu Wei	Executives
Zhou Ming	Executives
Zhuang Xian Min	Directors, executives
Zhang Yi	Executives
Liu Xi	Directors, executives
Sun Xiao Lin	Director
Yu Jian Ping	Executives

Beijing Strong Biotechnologies (SZSE:300406) Headlines

No Headlines